Table S2.
Results of mean H score from three independent pathologists
Tumor tissue | Control
|
Anti-PD-L1
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
#1 | #2 | #3 | #4 | #5 | #1 | #2 | #3 | #4 | #5 | ||
Pancreatic tumor | EXP.1 | 250 | 189 | 204 | 235 | 267 | 76 | 101 | 89 | 123 | 67 |
EXP.2 | 265 | 243 | 189 | 173 | – | 132 | 108 | 65 | 89 | 34 | |
EXP.3 | 213 | 209 | 198 | 89 | 179 | 89 | 79 | 68 | 134 | 76 | |
P-valuea | <0.0001 | ||||||||||
Liver tumor | EXP.1 | 209 | 167 | 195 | 132 | 89 | 112 | 54 | 98 | 45 | 76 |
EXP.2 | 198 | 138 | 119 | 165 | 72 | 76 | 32 | 128 | 21 | 19 | |
EXP.3 | 190 | 218 | 210 | 276 | – | 24 | 29 | 73 | 18 | 59 | |
P-valueb | <0.0001 |
Notes:
The differences in H score between Control and Anti-PD-L1 groups in pancreatic tumors.
The differences in H score between Control and Anti-PD-L1 groups in liver tumors. “–” denotes the mouse died before the end of the experiment.